This is Willow.
Pure. Precise. Proven.
This is Willow.
Pure. Precise. Proven.
Our Mission
Our goal at Willow is to commercialize high-value bio-products derived from plants. We do this by making key discoveries in plant genomics, and then translating these newly discovered genetic elements and biochemical strategies into the appropriate commercial host organism. We invite you to partner with us to enhance the success of your manufacturing program.
About Us
At Willow, our business is the discovery and commercialization of high-value bioproducts through biosynthesis.
What We Do
Commercial biosynthesis starts with understanding the plant’s genomics and pathway biochemistry, but yields a higher grade product for industrial and pharmaceutical needs.
Investors
Get more details about Willow.
Contact Us
Reach out and connect with us. Sign up for our newsletter.
Work at Willow
At Willow our business is to enable the commercialization of high-value bioproducts. We achieve this by making and deploying key discoveries in plant genomics and pathway biochemistry. Newly discovered genetic elements and biochemical mechanisms are transferred or translated into an appropriate industrial host organism, and optimized for maximum yield.
News and Press Releases
Willow Biosciences Announces Trading Date on the Toronto Stock Exchange
CALGARY, December 3, 2019 - Willow Biosciences Inc. ("Willow" or the "Company") (CSE: WLLW; OTCQB: CANSF) announces that it has received final approval from [...]
Willow Biosciences Comments on Descheduling of Partner’s Cannabidiol by U.S. Drug Enforcement Agency
CALGARY, Dec. 3, 2019 - Willow Biosciences Inc. ("Willow" or the "Company") (CSE: WLLW; OTCQB: CANSF), a Canadian biotechnology company and a leading [...]
Willow Biosciences Receives Conditional Approval to List on the Toronto Stock Exchange
CALGARY, November 25, 2019 - Willow Biosciences Inc. ("Willow" or the "Company") (CSE: WLLW; OTCQB: CANSF) announces that it has received conditional approval from the Toronto [...]
Willow Biosciences
Be the first to know. Sign up to receive news,
updates, investor information and more.